Enabling Gene-Edited hMSCs with a Fit-for-Purpose Transduction Agent
September 14, 2021
Tags:
Our Scientific Editor in Chief examines the therapeutic potential of gene-edited mesenchymal stem cells and some of the inherent challenges in transfection and transduction and highlights the benefits of RoosterBio's RoosterGEM medium in optimizing transduction.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
